Moderna's mRNA-1403 vaccine demonstrated strong antibody responses against prevalent norovirus genotypes in early-phase trials, utilizing similar technology to their COVID and RSV vaccines.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.